TP-452

N/A

Report date: 2022/08/24 20:00:31
NME

Base Information

Drug NameTP-452
Drug Alias NameDPA-FFA – Thetis
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHMG-CoA reductase inhibitorsProprotein convertase subtilisin kexin type 9 inhibitors
TargetsHMG-CoA reductaseProprotein convertase subtilisin kexin type 9
Therapy Area/IndicationsHypercholesterolemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThetis Pharmaceuticals Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThetis Pharmaceuticals Llc
Active IndicationsN/A
Inactive IndicationsHypercholesterolemia

Other Information

ATC CodeN/A
Related LinksN/A